Radcliffe Capital Management, L.P. - SUMMIT HEALTHCRE ACQUISTN CO ownership

SUMMIT HEALTHCRE ACQUISTN CO's ticker is and the CUSIP is G8566R110. A total of 22 filers reported holding SUMMIT HEALTHCRE ACQUISTN CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of SUMMIT HEALTHCRE ACQUISTN CO
ValueSharesWeighting
Q4 2022$1,001,498
+2.0%
99,900
-0.1%
0.03%
+33.3%
Q3 2022$982,000
+0.9%
100,0000.0%0.02%
+9.1%
Q2 2022$973,000
+0.2%
100,0000.0%0.02%0.0%
Q1 2022$971,000
+0.1%
100,0000.0%0.02%
-12.0%
Q4 2021$970,000
-0.5%
100,0000.0%0.02%
-10.7%
Q3 2021$975,000100,0000.03%
Other shareholders
SUMMIT HEALTHCRE ACQUISTN CO shareholders Q1 2022
NameSharesValueWeighting ↓
Athos Capital Ltd 149,999$1,5040.87%
Segantii Capital Management Ltd 600,000$6,015,0000.22%
LMR Partners LLP 1,041,281$10,438,8420.18%
BFAM Partners (Cayman) Ltd 550,000$155,6500.17%
Snow Lake Capital (HK) Ltd 500,000$135,0000.07%
Finepoint Capital LP 489,999$1390.04%
Radcliffe Capital Management, L.P. 99,900$1,001,4980.03%
Q Global Advisors, LLC 130,600$360.02%
Ovata Capital Management Ltd 150,000$410.01%
DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. 149,900$42,4220.01%
View complete list of SUMMIT HEALTHCRE ACQUISTN CO shareholders